Skip to main content
Fig. 2 | EJNMMI Radiopharmacy and Chemistry

Fig. 2

From: Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone

Fig. 2

Synthesis of alkyne precursor 5, non-radioactive mBPET-1, and mBRef-1. i) Br2, Et2O, 2 h, rt., 80%; ii) acetyl chloride, Et3N, THF, 5 min, 0 °C; iii) phenylacetylene, 5 mol% Pd (OAc)2, 7.5 mol% PtBu3*HBF4, 5 mol% CuI, diisopropylamine, 2 h, 60 °C; iv) KOH/aq. methanol, 2 h, 75 °C, 96%; v) p-HCHO, Et3N, MgCl2, acetonitrile, reflux, 19 h, 65%; vi) MeI, K2CO3, acetone, 18 h, 55 °C, quant.; vii) K2CO3, THF, reflux, 4 h, 14%; viii) NaBH3CN, acetic acid (cat.), methanol, 18 h, rt., 55%; ix) NaN3, DMF, 24 h, rt.; x) 10 mol% CuI, sodium ascorbate, diisopropylethylamine, H2O/MeCN/DMF, 2 h, rt., 25%; xi) NaBH3CN, acetic acid (cat.), methanol, 48 h, rt., 58%

Back to article page